+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dermatology Drugs Market by Route Of Administration (Injectable, Oral, Topical), Drug Class (Biologics, Calcineurin Inhibitors, Corticosteroids), Indication, Distribution Channel, Patient Age Group - Global Forecast 2025-2030- Product Image
Dermatology Drugs Market by Route Of Administration (Injectable, Oral, Topical), Drug Class (Biologics, Calcineurin Inhibitors, Corticosteroids), Indication, Distribution Channel, Patient Age Group - Global Forecast 2025-2030- Product Image
Sale

Dermatology Drugs Market by Route Of Administration (Injectable, Oral, Topical), Drug Class (Biologics, Calcineurin Inhibitors, Corticosteroids), Indication, Distribution Channel, Patient Age Group - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5967940
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The dermatology drugs market continues to evolve, presenting senior leaders with the challenge of balancing accelerated innovation, digital transformation, and changing regulatory and reimbursement frameworks. In response, industry stakeholders are adapting business strategies to optimize their commercial footprint and stay competitive within a multi-dimensional landscape.

Dermatology Drugs Market Snapshot

The Dermatology Drugs Market grew from USD 34.23 billion in 2024 to USD 37.71 billion in 2025. It is expected to continue growing at a CAGR of 9.99%, reaching USD 60.62 billion by 2030. This expansion reflects diverse drivers, including a surge in biologic approvals, upward movement in patient expectations, and greater global adoption of digital and precision therapies. These shifts are compelling companies to rethink innovation pipelines, refine commercialization models, and proactively address barriers across different health systems.

Scope & Segmentation

  • Route of Administration: Injectable, oral, and topical therapies—offering options spanning biologics, small molecules, creams, foams, gels, lotions, and ointments.
  • Drug Class: Biologics (including anti-TNF, IL-17 inhibitors, and IL-23 inhibitors), calcineurin inhibitors, corticosteroids, PDE4 inhibitors, and retinoids targeting immune pathways and inflammation.
  • Indications: Covering acne, atopic dermatitis, types of psoriasis (guttate, inverse, plaque), rosacea, and vitiligo—each bringing unique development priorities.
  • Distribution Channel: Hospital pharmacy, online pharmacy (over-the-counter and prescription drugs), and retail pharmacy—providing various access points and patient touchpoints.
  • Patient Age Group: Therapies adapted for adults, geriatrics, and pediatrics (adolescent, child, infant), ensuring appropriate dosing and safety.
  • Geographic Regions: Americas (including United States and key states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, and others), and Asia-Pacific (China, India, Japan, Australia, South Korea, and more).
  • Key Companies: AbbVie, Johnson & Johnson, Novartis, Regeneron, Eli Lilly, Pfizer, Sanofi, Bristol-Myers Squibb, Galderma, and LEO Pharma.

Key Takeaways for Decision-Makers

  • Emerging therapies fueled by advances in biologics and precision medicine are shifting treatment paradigms toward greater disease control and personalization.
  • Digital diagnostic tools and teledermatology solutions are expanding specialist reach, enriching patient data, and optimizing resource allocation across both traditional and online channels.
  • Strategic collaborations among biopharma firms, academic centers, and technology providers are accelerating discovery and speeding time-to-market for high-value therapies.
  • Adaptive regulatory pathways and real-world evidence generation are driving earlier and more informed approvals, increasing the need for integrated commercial and R&D planning.
  • Cost-containment initiatives and value-based contracting are compelling manufacturers to demonstrate real-world outcomes and align product positioning with payer priorities.
  • Regional variability in healthcare infrastructure and reimbursement is prompting localized go-to-market strategies, particularly in emerging Asia-Pacific and EMEA markets.

2025 US Tariff Impact: Supply Chain Resilience

Revised US tariff policies introduced in 2025 have reshaped procurement and manufacturing decisions. Pharmaceutical and biotech firms are responding with nearshoring and domestic production expansion, balancing import costs with the need for efficiency. These shifts are prompting new supplier contracts, closer collaboration with contract manufacturing partners, and enhanced inventory management to navigate potential bottlenecks and maintain pricing stability amid a changing trade environment.

Methodology & Data Sources

This analysis builds on structured interviews with key opinion leaders, regulatory authorities, and commercial strategists. Supplemented by extensive literature review and examination of corporate filings, our approach utilizes a multi-dimensional segmentation model for detailed comparisons. Country-level assessments consider reimbursement policy, health system capacity, and market access dynamics to support actionable insights.

Why This Report Matters

  • Enables senior executives to refine global and local market access strategies by clarifying regulatory shifts, digital transformation, and payer alignment trends.
  • Supports portfolio optimization through unique segmentation, helping prioritize resources toward high-growth therapy classes, patient groups, and regions.
  • Empowers supply chain and sourcing leaders to mitigate risks associated with tariff changes and rapidly evolving policy landscapes.

Conclusion

Sustained growth in the dermatology drugs sector requires integrating scientific advancement, digital enablement, and adaptive commercial models. By leveraging these insights, industry leaders can drive long-term value and deliver transformative dermatological therapies aligned with global and local market realities.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Widespread uptake of IL-17 and IL-23 inhibitors transforming moderate to severe psoriasis management
5.2. Growing investment in topical siRNA and gene silencing therapies for treatment-resistant atopic dermatitis
5.3. Expansion of teledermatology platforms driving remote monitoring and digital acne management solutions
5.4. Increasing focus on microbiome modulation with topical live biotherapeutic products for eczema control
5.5. Development of oral Janus kinase inhibitors offering faster relief for patients with chronic urticaria symptoms
5.6. Emergence of AI-driven diagnostic tools integrating imaging and patient data to personalize acne treatment regimens
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Dermatology Drugs Market, by Route Of Administration
8.1. Introduction
8.2. Injectable
8.2.1. Biologics
8.2.2. Small Molecules
8.3. Oral
8.4. Topical
8.4.1. Cream
8.4.2. Foam
8.4.3. Gel
8.4.4. Lotion
8.4.5. Ointment
9. Dermatology Drugs Market, by Drug Class
9.1. Introduction
9.2. Biologics
9.2.1. Anti-Tnf
9.2.2. Il-17 Inhibitors
9.2.3. Il-23 Inhibitors
9.3. Calcineurin Inhibitors
9.4. Corticosteroids
9.5. Pde4 Inhibitors
9.6. Retinoids
10. Dermatology Drugs Market, by Indication
10.1. Introduction
10.2. Acne
10.3. Atopic Dermatitis
10.4. Psoriasis
10.4.1. Guttate Psoriasis
10.4.2. Inverse Psoriasis
10.4.3. Plaque Psoriasis
10.5. Rosacea
10.6. Vitiligo
11. Dermatology Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.3.1. Over The Counter
11.3.2. Prescription Drugs
11.4. Retail Pharmacy
12. Dermatology Drugs Market, by Patient Age Group
12.1. Introduction
12.2. Adult
12.3. Geriatrics
12.4. Pediatrics
12.4.1. Adolescent
12.4.2. Child
12.4.3. Infant
13. Americas Dermatology Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Dermatology Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Dermatology Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Johnson & Johnson Services, Inc.
16.3.3. Novartis AG
16.3.4. Regeneron Pharmaceuticals, Inc.
16.3.5. Eli Lilly and Company
16.3.6. Pfizer Inc.
16.3.7. Sanofi S.A.
16.3.8. Bristol-Myers Squibb Company
16.3.9. Galderma S.A.
16.3.10. LEO Pharma A/S
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. DERMATOLOGY DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 12. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2030 (%)
FIGURE 14. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. DERMATOLOGY DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. DERMATOLOGY DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. DERMATOLOGY DRUGS MARKET: RESEARCHAI
FIGURE 26. DERMATOLOGY DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. DERMATOLOGY DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. DERMATOLOGY DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. DERMATOLOGY DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY SMALL MOLECULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY FOAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY FOAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY LOTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY LOTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ANTI-TNF, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ANTI-TNF, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-17 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-17 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-23 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY IL-23 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CALCINEURIN INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PDE4 INHIBITORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETINOIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ACNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ACNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ATOPIC DERMATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GUTTATE PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GUTTATE PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INVERSE PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INVERSE PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PLAQUE PSORIASIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROSACEA, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ROSACEA, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY VITILIGO, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY VITILIGO, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY OVER THE COUNTER, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PRESCRIPTION DRUGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GERIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY GERIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADOLESCENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY ADOLESCENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CHILD, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY CHILD, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INFANT, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY INFANT, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES DERMATOLOGY DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 153. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 154. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 155. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 156. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 157. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 158. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 159. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 160. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 161. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 162. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 163. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 164. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 165. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 166. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 167. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 168. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 169. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 170. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 171. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 172. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 173. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 174. CANADA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 175. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 176. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 177. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 178. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 179. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 180. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 181. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 184. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 185. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 188. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 189. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 190. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 191. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 192. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 193. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 194. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 195. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 196. MEXICO DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 197. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 198. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 199. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 200. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 201. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 202. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 219. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 222. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 223. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 224. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 225. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 226. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 241. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 242. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 243. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 244. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 245. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 246. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 247. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 250. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA DERMATOLOGY DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 265. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 266. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 267. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 268. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 269. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 270. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 271. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 272. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 273. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 274. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 275. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 287. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 290. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 291. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 292. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 293. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 294. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 295. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 296. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 297. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 298. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 299. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 300. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 301. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 302. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 303. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 304. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 305. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 306. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 307. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 308. GERMANY DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 309. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 312. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 313. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 314. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 315. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 316. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 317. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 318. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 319. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 320. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 321. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 322. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 323. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2018-2024 (USD MILLION)
TABLE 326. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY ONLINE PHARMACY, 2025-2030 (USD MILLION)
TABLE 327. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
TABLE 328. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY PATIENT AGE GROUP, 2025-2030 (USD MILLION)
TABLE 329. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2018-2024 (USD MILLION)
TABLE 330. FRANCE DERMATOLOGY DRUGS MARKET SIZE, BY PEDIATRICS, 2025-2030 (USD MILLION)
TABLE 331. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 332. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 333. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 334. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 335. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 336. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 337. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 338. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 339. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2018-2024 (USD MILLION)
TABLE 340. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY BIOLOGICS, 2025-2030 (USD MILLION)
TABLE 341. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 342. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 343. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2018-2024 (USD MILLION)
TABLE 344. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY PSORIASIS, 2025-2030 (USD MILLION)
TABLE 345. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 346. RUSSIA DERMATOLOGY DRUGS MARKET SIZE, BY DISTRIBUTION

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Dermatology Drugs market report include:
  • AbbVie Inc.
  • Johnson & Johnson Services, Inc.
  • Novartis AG
  • Regeneron Pharmaceuticals, Inc.
  • Eli Lilly and Company
  • Pfizer Inc.
  • Sanofi S.A.
  • Bristol-Myers Squibb Company
  • Galderma S.A.
  • LEO Pharma A/S

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 37.71 Billion
Forecasted Market Value ( USD ) by 2030 $ 60.62 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Dermatology Drugs - Global Strategic Business Report - Product Image

Dermatology Drugs - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Prescription Dermatology Therapeutics - Global Strategic Business Report - Product Image

Prescription Dermatology Therapeutics - Global Strategic Business Report

  • Report
  • 280 Pages
  • Global
From
Topical Drug Delivery Market by Product Type (Creams, Gels, Ointments), Delivery Technology (Active Delivery, Passive Delivery), Route of Administration, Formulation Type, Therapeutic Application, End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Topical Drug Delivery Market by Product Type (Creams, Gels, Ointments), Delivery Technology (Active Delivery, Passive Delivery), Route of Administration, Formulation Type, Therapeutic Application, End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Darier Disease Drugs Market by Drug Class (Anti Infectives, Corticosteroids, Retinoids), Route Of Administration (Oral, Parenteral, Topical), Distribution Channel, End User, Product Type - Global Forecast 2025-2030 - Product Image

Darier Disease Drugs Market by Drug Class (Anti Infectives, Corticosteroids, Retinoids), Route Of Administration (Oral, Parenteral, Topical), Distribution Channel, End User, Product Type - Global Forecast 2025-2030

  • Report
  • 183 Pages
  • Global
From
Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030) - Product Image

Dermatology Treatment and Care Market (2024 Edition): Analysis By Treatment Type (Skin Disease and Care, Hair Disease and Care), By Route of Administration, By End User, By Region: Market Insights and Forecast (2020-2030)

  • Report
  • 247 Pages
  • Global
From

About the Dermatological Drugs Market

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.